A natural PKM2 targeting agent as a potential drug for breast cancer treatment

A natural PKM2 targeting agent as a potential drug for breast cancer treatment

Bibliographic Details
Main Authors:	Xin‐Yue Shang, Yu‐Jue Wang, Zi‐Lin Hou, Xin‐Ye Wang, Hao Zhang, Chen‐Yu Yang, Ji‐Chong Li, Xiao‐Xiao Huang, Shao‐Jiang Song, Guo‐Dong Yao
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.1157

Similar Items

Transcriptomic signatures responding to PKM2 activator TEPP-46 in the hyperglycemic human renal proximal epithelial tubular cells
by: Zhimin Wang, et al.
Published: (2022-08-01)

The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues
by: Lin Li, et al.
Published: (2024-04-01)

PKM2–c-Myc–Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer
by: Pian Yu, et al.
Published: (2020-09-01)

PKM2 Nuclear Translocation Promotes Glial Cell Activation and Aggravates the Brain Injury of Intracerebral Hemorrhage
by: Xiao-Yi Xiong, et al.
Published: (2023-11-01)

The Structure and Dimensional Design of a Reconfigurable PKM
by: Xiaoqiang Tang, et al.
Published: (2013-06-01)

PKM2 coordinates glycolysis with mitochondrial fusion and oxidative phosphorylation
by: Tong Li, et al.
Published: (2019-03-01)

The Role of PKM2 in Diabetic Microangiopathy
by: Tu C, et al.
Published: (2022-05-01)

Overexpressed PKM2 promotes macrophage phagocytosis and atherosclerosis
by: Xiaochen Gai, et al.
Published: (2023-04-01)

Simultaneous suppression of PKM2 and PHGDH elicits synergistic anti-cancer effect in NSCLC
by: Kaixuan Wang, et al.
Published: (2023-05-01)

Improved Stiffness Modeling for An Exechon-Like Parallel Kinematic Machine (PKM) and Its Application
by: Nanyan Shen, et al.
Published: (2020-05-01)

Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection
by: Yao Wei, et al.
Published: (2020-02-01)

The eEF2 kinase-induced STAT3 inactivation inhibits lung cancer cell proliferation by phosphorylation of PKM2
by: Min Xiao, et al.
Published: (2020-02-01)

PKM2-Induced the Phosphorylation of Histone H3 Contributes to EGF-Mediated PD-L1 Transcription in HCC
by: Xiao Wang, et al.
Published: (2020-11-01)

PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment
by: Tian-En Li, et al.
Published: (2020-10-01)

The prognostic value of PKM2 and its correlation with tumour cell PD-L1 in lung adenocarcinoma
by: Chang-Ying Guo, et al.
Published: (2019-03-01)

Metabolic but not transcriptional regulation by PKM2 is important for natural killer cell responses
by: Jessica F Walls, et al.
Published: (2020-08-01)

Extracellular Vesicles Induce an Aggressive Phenotype in Luminal Breast Cancer Cells Via PKM2 Phosphorylation
by: Seo Young Kang, et al.
Published: (2021-12-01)

PKM2 promotes reductive glutamine metabolism
by: Miao Liu, et al.
Published: (2018-12-01)

Sistem penilaian kebergunaan PKM (SPKpkm)
by: Sahari @ Ashaari, Noraidah, et al.
Published: (2007)

PKM2, function and expression and regulation
by: Ze Zhang, et al.
Published: (2019-06-01)

PKM Mechatronic Clamping Adaptive Device
by: Alberto Borboni, et al.
Published: (2015-04-01)

PKM2 inhibition may reverse therapeutic resistance to transarterial chemoembolization in hepatocellular carcinoma
by: Sean P. Martin, et al.
Published: (2020-06-01)

PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
by: Jiao Feng, et al.
Published: (2019-05-01)

Single-Cell FISH Analysis Reveals Distinct Shifts in PKM Isoform Populations during Drug Resistance Acquisition
by: Seong Ho Kim, et al.
Published: (2022-08-01)

FOXM1D potentiates PKM2‐mediated tumor glycolysis and angiogenesis
by: Wei Zhang, et al.
Published: (2021-05-01)

Experimental Study of Hepatocellular Carcinoma Treatment by Shikonin Through Regulating PKM2
by: Liu T, et al.
Published: (2020-02-01)

TRAF6 promotes chemoresistance to paclitaxel of triple negative breast cancer via regulating PKM2‐mediated glycolysis
by: Han Xu, et al.
Published: (2023-10-01)

Potential of PKM2 as a drug target in mouse models with type 1 diabetes mellitus
by: Junbin Liu, et al.
Published: (2022-04-01)

Celastrol mitigates inflammation in sepsis by inhibiting the PKM2-dependent Warburg effect
by: Piao Luo, et al.
Published: (2022-05-01)

Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway
by: Xin Huang, et al.
Published: (2021-01-01)

PKM2 is not required for pancreatic ductal adenocarcinoma
by: Danai, Laura V, et al.
Published: (2018)

PKM INDUSTRI KRUPUK LEMPENG DI BANTUL
by: Sri Setyowati, et al.
Published: (2019-12-01)

Involvement of PKMζ in Stress Response and Depression
by: Jianfeng Liu
Published: (2022-05-01)

Memory maintenance by PKMζ — an evolutionary perspective
by: Sacktor Todd
Published: (2012-09-01)

PKM2 is not required for pancreatic ductal adenocarcinoma
by: Alissandra L Hillis, et al.
Published: (2018-10-01)

IGF2BP3 May Contributes to Lung Tumorigenesis by Regulating the Alternative Splicing of PKM
by: Huang Xueqing, et al.
Published: (2020-09-01)

PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis
by: Ji Liang, et al.
Published: (2016-08-01)

Role of PKM2-Mediated Immunometabolic Reprogramming on Development of Cytokine Storm
by: Zhijun Liu, et al.
Published: (2021-10-01)

High Expression of PKM2 Was Associated with the Poor Prognosis of Acute Leukemia
by: Huang Y, et al.
Published: (2021-10-01)

YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis
by: Xuemei Yao, et al.
Published: (2022-03-01)